“The project results were so significant that we were able to secure additional business in an environment where a few months earlier we had thought we were at maximum capacity.” – Pharmaceutical Company

Featured Clients

  • Boston Scientific
  • Foundation Health Systems
  • King Pharmaceuticals
  • Pharmacia Upjohn

Select a Capability



Satisfaction Ratings

Clients Give USCCG High Marks

USCCG Client Satisfaction Ratings (Through 9/22/11)

Overall Satisfaction 95.9 percent of USCCG clients expressed overall satisfaction with the firm with 81.0 percent saying they were “extremely” or “very” satisfied.

Case Histories

Manufacturer of medical supplies wanted to reduce inventory while improving its materials management and planning system.

SEE MORE CASE HISTORIES

Testimonials

"USCCG representatives have been on duty around the clock with production employees directly involved with the work of making metal." – Aluminum Producer

SEE MORE TESTIMONIALS

Challenge - Maximizing Asset Utilization

Pharmaceutical maufacturers are evolving from high-margin, large-volume, make-to-stock, supply-drive operations to price sensitive, small volume, flexible, make-to-order, personalized, and value-driven operations. With limited available capital, equipment, and talented human assets, maximizing asset utiliation and return on assets is becoming vital to future success and survival.

What We Think

“As the evolution continues many Life Sciences companies will take tentative steps to improve ROA while others will consider these times not evolutionary but, revolutionary. Those will be the ones that gobble up their competition. Consolidation will continue.”

– J. Michael Spratt, Life Sciences Practice Leader

  • Incoming inspection and quarantine
  • Clean room environments
  • Weighing, milling and blending rooms
  • Delivery methods including liquid, suspensions, gelcaps, tablets and softgels
  • Various molding including injection, silicone and rubber
  • Various packaging methods including bottle, multivac and hand assembly
  • Laboratory testing and release
  • Sterilization including both gamma and eto
  • Repeatable process
  • Improved yield and product quality
  • Improved asset utilization
  • Lower operating costs
  • Improved customer service and satisfaction
  • Increased throughput
  • Less waste
  • Reduced process variation
  • Reduced cost of compliance
  • Increased market share and revenue
  • Shorter order-to-delivery cycle times
  • Reduced costs to convert raw materials to finished goods
  • Reduced work in progress and inventory levels